Literature DB >> 23455886

Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival.

Vincent Bourgade1, Sarah J Drouin, David R Yates, Jerôme Parra, Marc-Olivier Bitker, Olivier Cussenot, Morgan Rouprêt.   

Abstract

OBJECTIVE: Our aim was to assess the effect of surgical wait time on the survival of patients with urological neoplasms, including prostate, bladder, penile, and testicular cancers and upper tract tumours (UTUC).
MATERIALS AND METHODS: Current, relevant studies were identified from the literature. Keywords used for article retrieval were as follows: delay; surgery; prostate cancer; urothelial carcinoma; renal cell carcinoma; testicular cancer; bladder; renal pelvis; ureter; and survival.
RESULTS: Regarding the length of surgical wait time, it does not matter in cases of incidental T1a renal cell carcinomas. In other cases of renal cell carcinomas, surgery should be considered within <1 month; it is of crucial importance in bladder cancer and should be <1 month for a TURBT in cases of non-muscle-invasive bladder cancer and <1 month for a radical cystectomy in cases of muscle-invasive bladder cancer; it is important in invasive UTUC and should be <1 month for a radical nephroureterectomy; it is not crucial in cases of low-risk prostate cancer. In any other case, radical prostatectomy should be considered within <2 months; it is important in testicular cancer and should be fewer than 10 days for an orchiectomy.
CONCLUSION: Prolonged surgical wait times have an impact on the overall quality of life and anxiety of the patient. Extending the wait time beyond a given threshold can also have a negative impact on the patient's clinical outcomes, but this threshold differs between urological neoplasms.

Entities:  

Mesh:

Year:  2013        PMID: 23455886     DOI: 10.1007/s00345-013-1045-z

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  39 in total

1.  Waiting times for cancer patients in England after general practitioners' referrals: retrospective national survey.

Authors:  P Spurgeon; F Barwell; D Kerr
Journal:  BMJ       Date:  2000-03-25

Review 2.  Clinical practice. Small renal mass.

Authors:  Inderbir S Gill; Monish Aron; Debra A Gervais; Michael A S Jewett
Journal:  N Engl J Med       Date:  2010-02-18       Impact factor: 91.245

3.  Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project.

Authors:  Badrinath R Konety; Vibhu Dhawan; Veerasathpurush Allareddy; Sue A Joslyn
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

4.  [Clinical pattern and therapeutic results obtained in Germ-Cell testicular cancer in Spain based on a consecutive series of 1250 patients].

Authors:  J R Germà; X García Del Muro; P Maroto; P Lianes; J A Arranz; J Gumà; J Aparicio; J Sastre; E Alba; J Terrasa; A Sáenz; A Fernández
Journal:  Med Clin (Barc)       Date:  2001-04-07       Impact factor: 1.725

Review 5.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

6.  Upper tract urothelial carcinoma: impact of time to surgery.

Authors:  Debasish Sundi; Robert S Svatek; Vitaly Margulis; Christopher G Wood; Surena F Matin; Colin P Dinney; Ashish M Kamat
Journal:  Urol Oncol       Date:  2010-09-25       Impact factor: 3.498

7.  Waiting for elective surgery: effects on health-related quality of life.

Authors:  S Derrett; C Paul; J M Morris
Journal:  Int J Qual Health Care       Date:  1999-02       Impact factor: 2.038

8.  The '2-week wait' rule for referrals for suspected urological cancers--urgent need for refinement of criteria.

Authors:  Amr M Hawary; Hazel E Warburton; Richard J Brough; Gerald N Collins; Stephen C Brown; Patrick H O'Reilly; Adebanji Ab Adeyoju
Journal:  Ann R Coll Surg Engl       Date:  2008-09       Impact factor: 1.891

Review 9.  Is surveillance an option for the treatment of small renal masses?

Authors:  Hendrik Van Poppel; Steven Joniau
Journal:  Eur Urol       Date:  2007-07-23       Impact factor: 20.096

10.  Longer wait times increase overall mortality in patients with bladder cancer.

Authors:  Girish S Kulkarni; David R Urbach; Peter C Austin; Neil E Fleshner; Andreas Laupacis
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

View more
  21 in total

1.  Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.

Authors:  Dawei Li; Zhen Han; Jikai Liu; Xiang Zhang; Juchao Ren; Lei Yan; Hainan Liu; Zhonghua Xu
Journal:  Med Oncol       Date:  2013-09-03       Impact factor: 3.064

2.  Surgery: surgical wait times for UTUC-a race against the clock?

Authors:  Morgan Rouprêt
Journal:  Nat Rev Urol       Date:  2014-09-02       Impact factor: 14.432

3.  Does surgical delay for radical prostatectomy affect patient pathological outcome? A retrospective analysis from a Canadian cohort.

Authors:  Marc Zanaty; Mansour Alnazari; Kelsey Lawson; Mounsif Azizi; Emad Rajih; Abdullah Alenizi; Pierre-Alain Hueber; Malek Meskawi; Cedric Lebacle; Thierry Lebeau; Serge Benayoun; Pierre I Karakiewicz; Assaad El-Hakim; Kevin C Zorn
Journal:  Can Urol Assoc J       Date:  2017-08       Impact factor: 1.862

Review 4.  Cost-effectiveness of Common Diagnostic Approaches for Evaluation of Asymptomatic Microscopic Hematuria.

Authors:  Joshua A Halpern; Bilal Chughtai; Hassan Ghomrawi
Journal:  JAMA Intern Med       Date:  2017-06-01       Impact factor: 21.873

5.  Waiting Times for Prostate Cancer Diagnosis in a Nigerian Population.

Authors:  Olufunmilade A Omisanjo; Olawale O Ogunremi; Olufemi O Akinola; Olaolu O Adebayo; Olufemi Ojewuyi; Mofeyisayo O Omorinde; Abimbola A Abolarinwa; Stephen O Ikuerowo; Fatai A Balogun
Journal:  J Cancer Epidemiol       Date:  2021-08-16

6.  Is time from diagnosis to radical prostatectomy associated with oncological outcomes?

Authors:  Kirsti Aas; Sophie Dorothea Fosså; Rune Kvåle; Bjørn Møller; Tor Åge Myklebust; Ljiljana Vlatkovic; Stig Müller; Viktor Berge
Journal:  World J Urol       Date:  2018-11-27       Impact factor: 4.226

7.  Assessment of the effect of interval from presentation to surgery on outcome in patients with peri-ampullary malignancy.

Authors:  Bassem Amr; Golnaz Shahtahmassebi; Christopher D Briggs; Matthew J Bowles; Somaiah Aroori; David A Stell
Journal:  HPB (Oxford)       Date:  2016-02-03       Impact factor: 3.647

8.  Prediction of metastatic status in non-seminomatous testicular cancer.

Authors:  C G Ruf; S Sachs; N Khalili-Harbi; H Isbarn; W Wagner; C Matthies; V Meineke; M Fisch; F K Chun; M Abend
Journal:  World J Urol       Date:  2013-10-29       Impact factor: 4.226

9.  Impact of Surgical Wait Time on Survival in Patients With Upper Urinary Tract Urothelial Carcinoma With Hydronephrosis.

Authors:  Fangzheng Zhao; Nienie Qi; Chu Zhang; Ning Xue; Shuaishuai Li; Raorao Zhou; Zeyu Chen; Ruiqin Yao; Haitao Zhu
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

10.  Time from diagnosis to surgery and prostate cancer survival: a retrospective cohort study.

Authors:  Maria Theresa Redaniel; Richard M Martin; David Gillatt; Julia Wade; Mona Jeffreys
Journal:  BMC Cancer       Date:  2013-11-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.